Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BL.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BL.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BL.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BL.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BL.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.11.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.11.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.11.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.11.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBF.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBF.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BZ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BZ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.10.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.10.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.10.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used